Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-038543
Filing Date
2024-08-27
Accepted
2024-08-27 16:35:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A noticeandaccesscardfy24pro.htm DEFA14A 36564
  Complete submission text file 0001628280-24-038543.txt   37926
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-11504 | Film No.: 241249574
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)